These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31939034)

  • 1. Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis.
    Morino K; Seo S; Yoh T; Fukumitsu K; Ishii T; Taura K; Morita S; Kaido T; Uemoto S
    Ann Surg Oncol; 2020 Jun; 27(6):1908-1917. PubMed ID: 31939034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.
    Miyazaki Y; Kokudo T; Amikura K; Kageyama Y; Takahashi A; Ohkohchi N; Sakamoto H
    Jpn J Clin Oncol; 2017 Mar; 47(3):206-212. PubMed ID: 27940488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
    Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
    J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Benefits of Surgical Resection in Patients with Recurrent Biliary Tract Carcinoma.
    Motoyama H; Kobayashi A; Yokoyama T; Shimizu A; Kitagawa N; Notake T; Fukushima K; Masuo H; Yoshizawa T; Miyagawa SI
    World J Surg; 2017 Nov; 41(11):2817-2829. PubMed ID: 28717913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery.
    Akazawa Y; Mizuno S; Fujinami N; Suzuki T; Yoshioka Y; Ochiya T; Nakamoto Y; Nakatsura T
    Sci Rep; 2019 Apr; 9(1):5925. PubMed ID: 30976046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of lung recurrence in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Serikawa M; Ishii Y; Arihiro K; Murakami Y; Murashita J; Takahashi S
    Langenbecks Arch Surg; 2023 Jul; 408(1):290. PubMed ID: 37522989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Oligometastasis in Biliary Tract Cancer and Impact on Survival Outcomes.
    Okamoto T; Takeda T; Sasaki T; Inoue Y; Mie T; Hirai T; Ishitsuka T; Yamada M; Nakagawa H; Furukawa T; Kasuga A; Ozaka M; Takahashi Y; Sasahira N
    J Gastrointest Cancer; 2024 Dec; 55(4):1530-1540. PubMed ID: 39145915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis.
    Ji JH; Kim YS; Park I; Lee SI; Kim RB; Park JO; Oh SY; Hwang IG; Jang JS; Song HN; Kang JH
    Cancer Res Treat; 2018 Jul; 50(3):791-800. PubMed ID: 28838033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?
    Sakata J; Nomura T; Aono T; Kitami C; Yokoyama N; Minagawa M; Takizawa K; Miura K; Hirose Y; Ichikawa H; Nagahashi M; Shimada Y; Kobayashi T; Wakai T
    HPB (Oxford); 2021 Sep; 23(9):1371-1382. PubMed ID: 33558069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group.
    Matsukuma S; Nagano H; Kobayashi S; Wada H; Seo S; Tsugawa D; Okuyama H; Iida K; Ohmura Y; Takeda Y; Miyamoto A; Nakashima S; Yamada T; Ajiki T; Tsuji A; Yoshimura K; Eguchi H; Hatano E; Ioka T;
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1323. PubMed ID: 33283475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
    Sebbagh S; Roux J; Dreyer C; Neuzillet C; de Gramont A; Orbegoso C; Hentic O; Hammel P; de Gramont A; Raymond E; André T; Chibaudel B; Faivre S
    Acta Oncol; 2016; 55(9-10):1168-1174. PubMed ID: 27333436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of initial disease recurrence after resection of biliary tract cancer.
    Jung SJ; Woo SM; Park HK; Lee WJ; Han MA; Han SS; Kim SH; Park SJ; Kim TH; Koh YH; Hong EK
    Oncology; 2012; 83(2):83-90. PubMed ID: 22777276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical outcomes of multicentric adenocarcinomas of the biliary tract.
    Kobayashi S; Konishi M; Kato Y; Gotohda N; Takahashi S; Kinoshita T; Kinoshita T; Kojima M
    Jpn J Clin Oncol; 2011 Sep; 41(9):1079-85. PubMed ID: 21875937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases.
    Takahara N; Nakai Y; Isayama H; Sasaki T; Saito K; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Takeda T; Saito T; Mizuno S; Kogure H; Tada M; Koike K
    Invest New Drugs; 2018 Dec; 36(6):1093-1102. PubMed ID: 30324343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of salvage chemoradiotherapy for locally recurrent biliary tract cancer.
    Il Yu J; Chul Park H; Hoon Lim D; Oh Park J; Suk Park Y; Tae Kim S; Ho Choi S; Wook Choi D; Woong Han I; Seok Heo J
    Tumori; 2017 Jul; 103(4):345-352. PubMed ID: 28708225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and risk stratification in unresectable biliary tract cancers undergoing radiation therapy.
    Amit U; Shagun M; Plastaras JP; Metz JM; Karasic TB; Lubas MJ; Ben-Josef E
    Radiat Oncol; 2024 Aug; 19(1):102. PubMed ID: 39090660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer.
    Chung MJ; Lee KJ; Bang S; Park SW; Kim KS; Lee WJ; Song SY; Chung JB; Park JY
    Ann Surg Oncol; 2011 Jun; 18(6):1651-6. PubMed ID: 21210227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of differentiation at the invasive front of biliary tract cancer.
    Okubo S; Mitsunaga S; Kato Y; Kojima M; Sugimoto M; Gotohda N; Takahashi S; Hayashi R; Konishi M
    J Surg Oncol; 2018 May; 117(6):1278-1287. PubMed ID: 29572828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.
    Lee J; Park JH; Lee CR; Chung WY; Park CS
    Thyroid; 2013 Nov; 23(11):1408-15. PubMed ID: 23509895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.